Search: onr:"swepub:oai:DiVA.org:umu-35056" >
Management of neuro...
Management of neuronopathic Gaucher disease : revised recommendations
-
Vellodi, A (author)
-
Tylki-Szymanska, A (author)
-
Davies, E H (author)
-
show more...
-
Kolodny, E (author)
-
Bembi, B (author)
-
Collin-Histed, T (author)
-
Mengel, E (author)
-
- Erikson, Anders (author)
- Umeå universitet,Pediatrik
-
Schiffmann, R (author)
-
show less...
-
(creator_code:org_t)
- 2009-08-05
- 2009
- English.
-
In: Journal of Inherited Metabolic Disease. - : Springer. - 0141-8955 .- 1573-2665. ; 32:5, s. 660-664
- Related links:
-
https://urn.kb.se/re...
-
show more...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- The original guidelines drawn up for the management of the neuronopathic forms of Gaucher disease were felt to be in need of revision; in particular, the role of high-dose enzyme replacement therapy (120 IU/kg of body weight every 2 weeks) in stabilizing neurological disease. The existing published evidence was analysed; it was concluded that it did not support the role of high-dose ERT, although this might be required to treat severe visceral disease.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Pediatrik (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Pediatrics (hsv//eng)
Keyword
- neuronopathic
- Gaucher disease
- revised recommendations
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database